اخبار و اعلانات

 آمار

تعداد نشریات282
تعداد نشریات سازمان80
تعداد شماره‌ها3,262
تعداد مقالات36,059
تعداد مشاهده مقاله55,192,113
تعداد دریافت فایل اصل مقاله94,189,944
Sabah Abdulridha Budair, A, Ismail Al Hamdi, K, Ali Mansour, A. (1400). Non-Infectious Dermatological Manifestations among Patients with Diabetes Mellitus in Basrah, Iraq. سامانه مدیریت نشریات علمی, 77(1), 467-475. doi: 10.22092/ari.2021.356588.1874
A Sabah Abdulridha Budair; K Ismail Al Hamdi; A Ali Mansour. "Non-Infectious Dermatological Manifestations among Patients with Diabetes Mellitus in Basrah, Iraq". سامانه مدیریت نشریات علمی, 77, 1, 1400, 467-475. doi: 10.22092/ari.2021.356588.1874
Sabah Abdulridha Budair, A, Ismail Al Hamdi, K, Ali Mansour, A. (1400). 'Non-Infectious Dermatological Manifestations among Patients with Diabetes Mellitus in Basrah, Iraq', سامانه مدیریت نشریات علمی, 77(1), pp. 467-475. doi: 10.22092/ari.2021.356588.1874
Sabah Abdulridha Budair, A, Ismail Al Hamdi, K, Ali Mansour, A. Non-Infectious Dermatological Manifestations among Patients with Diabetes Mellitus in Basrah, Iraq. سامانه مدیریت نشریات علمی, 1400; 77(1): 467-475. doi: 10.22092/ari.2021.356588.1874

Non-Infectious Dermatological Manifestations among Patients with Diabetes Mellitus in Basrah, Iraq

Archives of Razi Institute
مقاله 57، دوره 77، شماره 1، فروردین و اردیبهشت 2022، صفحه 467-475    اصل مقاله (522.45 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2021.356588.1874
نویسندگان
A Sabah Abdulridha Budair* 1؛ K Ismail Al Hamdi2؛ A Ali Mansour1
1Faiha Specialized Diabetes, Endocrine, and Metabolism Center, University of Basrah, Basrah, Iraq
2College of Medicine, University of Basrah, Basrah, Iraq
چکیده
Diabetes mellitus (DM) is a clinical illness usually linked to a wide range of skin manifestations; however, skin, as the greatest organ in the body, has received little attention. As a result, this study aimed to detect the prevalence and pattern of non-infectious skin disorders among patients with diabetes. This study was carried out at the Faiha Specialized Diabetes, Endocrine, and Metabolism Center, Basrah Province, Iraq, from September 2020 to September 2021. The data were collected from 347 patients with Type 1 diabetes mellitus (T1DM) and Type 2 diabetes mellitus (T2DM). The exclusion criteria were patients with skin changes due to some medications, pregnancy, iatrogenic factors, skin infections, established hypo- or hyper-thyroidism, Cushing or adrenal insufficiency, pituitary disorders, end-stage renal impairment, malignancy, and established rheumatological disease and those who were on chemotherapy. Full dermatological examinations and screenings were performed under the supervision of a dermatologist expert and all clinically definable cutaneous lesions were recorded. The prevalence of skin lesions was estimated at 71.5% in patients. Pruritus, xerosis, acrochordon, diabetic dermopathy, acanthosis nigricans, and insulin-related lipohypertrophy were the commonest skin lesions reported among the patients. The occurrence of skin lesions in diabetic patients was proportional to the female gender, duration of disease, obesity, insulin therapy, and worse glycemic control. There was a broad spectrum of skin lesions in both T1DM and T2DM with corresponding prevalence.
کلیدواژه‌ها
Iraq؛ Skin lesion؛ T1DM؛ Pruritus؛ T2DM؛ Xerosis
سایر فایل های مرتبط با مقاله
مراجع
  1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.
  2. Shah I, Wadhwa V, Bilal M, Germansky KA, Sawhney MS, Mlabasati J, et al. Prospective assessment for prediabetes and new-onset diabetes in high-risk individuals undergoing pancreatic cancer screening. Gastroenterology. 2021.
  3. Kolodziejski PA, Leciejewska N, Chmurzynska A, Sassek M, Szczepankiewicz A, Szczepankiewicz D, et al. 30-Day spexin treatment of mice with diet-induced obesity (DIO) and type 2 diabetes (T2DM) increases insulin sensitivity, improves liver functions and metabolic status. Mol Cell Endocrinol. 2021;536:111420.
  4. Conlon JM, Mechkarska M, Lukic ML, Flatt PR. Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides. 2014;57:67-77.
  5. Sothornwit J, Srisawasdi G, Suwannakin A, Sriwijitkamol A. Decreased health-related quality of life in patients with diabetic foot problems. Diabetes Metab Syndr Obes. 2018;11:35.
  6. de Macedo GMC, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. D Diabetes Metab Syndr. 2016;8(1):1-8.
  7. Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous manifestations of diabetes mellitus. Clin Diabetes. 2015;33(1):40-8.
  8. Ahmed K, Muhammad Z, Qayum I. Prevalence of cutaneous manifestations of diabetes mellitus. J Ayub Med Coll Abbottabad. 2009;21(2):76-9.
  9. Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol. 2012;26(10):1203-11.
  10. Ko M-J, Chiu H-C, Jee S-H, Hu F-C, Tseng C-H. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol. 2013;23(5):688-93.
  11. Sun P-C, Chen C-S, Kuo C-D, Lin H-D, Chan R-C, Kao M-J, et al. Impaired microvascular flow motion in subclinical diabetic feet with sudomotor dysfunction. Microvasc Res. 2012;83(2):243-8.
  12. Park HY, Kim JH, Jung M, Chung CH, Hasham R, Park CS, et al. A long‐standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Exp Dermatol. 2011;20(12):969-74.
  13. Uhoda E, Debatisse B, Paquet P, Piérard-Franchimont C, Piérard G. The so-called dry skin of the diabetic patient. Rev Med Liege. 2005;60(5-6):560-3.
  14. Williams DS. Acanthosis nigricans. J Insur Med. 2005;37(2):166.
  15. Radermecker RP, Scheen A. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev. 2007;23(5):348-55.
  16. Strak SK. The Pattern of Skin Lesion in a Sample of Iraqi Diabetic Patients. Iraqi J Community Med. 2006;19(1).
  17. Yasso FS, Yaso SS, Yasso PS. Skin manifestations of diabetes mellitus among Iraqi patients. Am J Med Stud. 2013;1(3):32-7.
  18. Chatterjee N, Chattopadhyay C, Sengupta N, Das C, Sarma N, Pal SK. An observational study of cutaneous manifestations in diabetes mellitus in a tertiary care Hospital of Eastern India. Indian J Endocrinol Metab. 2014;18(2):217.
  19. Salari N, Hosseinian-Far A, Hosseinian-Far M, Kavoussi H, Jalali R, Vaisi-Raygani A, et al. Evaluation of skin lesions in diabetic patients: a systematic review and meta-analysis. J Diabetes Metab Disord. 2020:1-8.
  20. Verma A, Pandya P, Sharma D. Skin manifestations in patients with type-II diabetes mellitus. Int J Inf Res Rev. 2019;6(9):59-65.
  21. Mahajan S, Koranne R, Sharma S. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol. 2003;69(2):105-8.
  22. Shahzad M, Al Robaee A, Al Shobaili HA, Alzolibani AA, Al Marshood AA, Al Moteri B. Skin manifestations in diabetic patients attending a diabetic clinic in the Qassim region, Saudi Arabia. Med Princ Pract. 2011;20(2):137-41.
  23. Vahora R, Thakkar S, Marfatia Y. Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat. Indian J Endocrinol Metab. 2013;17(4):659.
  24. Zimmo SK. Prevalence of skin manifestations in diabetes mellitus at King Abdulaziz University hospital. Saudi J Intern Med. 2012;2(1):19-22.
  25. Mutairi N, Amr Z, Sharma A, Sheltani M. Cutaneous Manifestation of Diabetes Mellitus, Study from Department of Dermatology, Farwaniya Hospital, Kuwait. Med Princ Pract. 2006;15:427-30.
  26. Krajnik M, Zylicz Z. Understanding pruritus in systemic disease. J Pain Symptom Manage. 2001;21(2):151-68.
  27. Mishra D. To determine cutaneous manifestation in diabetes patients-A clinical study. Int J Dermatol Venereology Leprosy Sci. 2018;1:16-8.
  28. Nigam P, Pande S. Pattern of dermatoses in diabetics. Indian J Dermatol Venereol Leprol. 2003;69(2):83-5.
  29. Niaz F, Bashir F, Shams N, Shaikh Z, Ahmed I. Cutaneous manifestations of diabetes mellitus type 2: prevalence and association with glycemic control. J Pak Assoc Dermatol. 2016;26(1):4-11.
  30. Sanad EM, ElFangary MM, Sorour NE, ElNemisy NM. Skin manifestations in Egyptian diabetic patients: a case series study. Egypt J Dermatol Venerol. 2013;33(2):56.
  31. Alwaash SS, Al-Shibly K. Dermatological manifestations of diabetes mellitus in Hilla City. Med J Babylon. 2017;14(3):495-500.
  1. Ozlu E, Uzuncakmak TK, Takır M, Akdeniz N, Karadag AS. Comparison of cutaneous manifestations in diabetic and nondiabetic obese patients: A prospective, controlled study. North Clin Istanb. 2018;5(2):114.
  2. Mansour AA, Alibrahim NT, Alidrisi HA, Alhamza AH, Almomin AM, Zaboon IA, et al. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period. Diabetes Metab Syndr: Clin Res Rev. 2020;14(3):265-72.
  1. Gentile S, Strollo F, Viazzi F, Russo G, Piscitelli P, Ceriello A, et al. Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions. J Diabetes Res. 2018;2018.
  2. Vathsala S, Murthy SC, Shashibhushan J. Cutaneous manifestations in diabetes mellitus: a study among 500 patients in a tertiary care center in South India. IP Indian J Clin Exp Dermatol. 2019;5(2):141-5.
آمار
تعداد مشاهده مقاله: 2,588
تعداد دریافت فایل اصل مقاله: 3,565


counter
سامانه مدیریت نشریات علمی. طراحی و پیاده سازی از سیناوب